Cognitive deficits are usually mild in patients with breast cancer after chemotherapy

Alterations in serum levels of trace element in patients with breast cancer before and after chemotherapy

Background: Breast cancer is the most common serious disease around the world. The trace elements have a vital role in the metabolism and chemotherapy may change the level of metal ions. Due to the ambiguity of the existence in this regard, the study examined the trace element serum levels in women with breast cancer before and after chemotherapy . Methods: Sixty patients were studied undergoi...

Predictors of cognitive decline after chemotherapy in breast cancer patients.

The objective of this study is to identify whether decline in cognitive functioning after chemotherapy in women with breast cancer is associated with health/disease, treatment, and psychological variables. Neuropsychological performance, health/disease, and treatment-related information of 136 women with breast cancer (age M = 49.38; SD = 7.92; range = 25.25-67.92) was assessed pre-chemotherapy...

Occurrence of Secondary Acute Myeloid Leukemia in a Patient with Breast Cancer after Chemotherapy

Surgery after Primary Systemic Chemotherapy in Patients with Breast Cancer

Zusammenfassung Die systemische Therapie beim kurablen Mammakarzinom wird zunehmend der Operation im Sinne einer «neo-adjuvanten» Behandlung – oder besser primär systemischen Therapie (PST) – vorangestellt. Sowohl aus klinischen als auch aus wissenschaftlichen Gründen bietet dieses Behandlungskonzept viele Vorteile. Für die Betroffenen steht die Möglichkeit im Vordergrund, die Rate der brusterh...

Sustained attention abnormalities in breast cancer survivors with cognitive deficits post chemotherapy: An electrophysiological study.

OBJECTIVE Many breast cancer survivors (BCS) report cognitive problems following chemotherapy, yet controversy remains concerning which cognitive domains are affected. This study investigated a domain crucial to daily function: the ability to maintain attention over time. METHODS We examined whether BCS who self-reported cognitive problems up to 3 years following cancer treatment (n=19) perfo...